a:2:{s:7:"current";a:10:{s:4:"date";s:0:"";s:7:"creator";s:0:"";s:4:"user";s:0:"";s:11:"last_change";s:0:"";s:11:"contributor";s:0:"";s:5:"title";s:0:"";s:11:"description";s:0:"";s:8:"relation";s:0:"";s:8:"internal";s:0:"";s:11:"plugin_move";s:0:"";}s:10:"persistent";a:6:{s:4:"date";a:2:{s:7:"created";i:1412341086;s:8:"modified";i:1421745104;}s:7:"creator";s:15:"CAcert WoT User";s:4:"user";s:25:"pierre.veyre@bioaster.org";s:11:"last_change";a:7:{s:4:"date";i:1421745104;s:2:"ip";s:10:"10.69.1.92";s:4:"type";s:1:"C";s:2:"id";s:57:"ut6:choix_d_un_e-crf_pour_la_gestion_des_etudes_cliniques";s:4:"user";s:26:"nicolas.sapay@bioaster.org";s:3:"sum";s:130:"Page moved from choix_d_un_e-crf_pour_la_gestion_des_etudes_cliniques to ut6:choix_d_un_e-crf_pour_la_gestion_des_etudes_cliniques";s:5:"extra";s:0:"";}s:11:"contributor";a:4:{s:25:"pierre.veyre@bioaster.org";s:15:"CAcert WoT User";s:26:"nicolas.sapay@bioaster.org";N;s:24:"karen.louis@bioaster.org";s:15:"CAcert WoT User";s:29:"tanguy.lecarrour@bioaster.org";N;}s:11:"plugin_move";a:2:{s:7:"old_ids";a:2:{s:53:"choix_d_un_e-crf_pour_la_gestion_des_etudes_cliniques";i:1421745104;s:61:"ccin2p3:choix_d_un_e-crf_pour_la_gestion_des_etudes_cliniques";i:1421051715;}s:11:"media_moves";a:6:{s:29:"pt1:plaquette_openclinica.pdf";s:33:"ut6:pt1:plaquette_openclinica.pdf";s:30:"pt1:oce_cutraining_support.pdf";s:34:"ut6:pt1:oce_cutraining_support.pdf";s:21:"pt1:oc_enterprise.pdf";s:25:"ut6:pt1:oc_enterprise.pdf";s:43:"pt1:five_guidelines_building_studies_wp.pdf";s:47:"ut6:pt1:five_guidelines_building_studies_wp.pdf";s:16:"pt1:ecrf-fda.pdf";s:20:"ut6:pt1:ecrf-fda.pdf";s:28:"pt1:e-crf_02_10_2014_vf.pptx";s:32:"ut6:pt1:e-crf_02_10_2014_vf.pptx";}}}}